SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-20-005433
Filing Date
2020-04-24
Accepted
2020-04-24 16:02:57
Documents
7
Period of Report
2020-06-11
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 AERIEPROXY2020 aerieproxy2020.htm DEF 14A 1335728
2 aerilogoa02.jpg GRAPHIC 48344
3 annualceopayvsstockprice02.jpg GRAPHIC 45912
4 AERIESTOCKPRICE comparisonoffiveyearcumulat.jpg GRAPHIC 52391
5 grantdatefairvalueo.jpg GRAPHIC 42495
6 signature1a02.jpg GRAPHIC 7059
7 signature2a02.jpg GRAPHIC 10599
  Complete submission text file 0001628280-20-005433.txt   1600763
Mailing Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703
Business Address 4301 EMPEROR BOULEVARD SUITE 400 DURHAM NC 27703 (919) 237-5300
AERIE PHARMACEUTICALS INC (Filer) CIK: 0001337553 (see all company filings)

IRS No.: 203109565 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36152 | Film No.: 20814917
SIC: 2836 Biological Products, (No Diagnostic Substances)